Ownership history in Palogic Value Management, L.P. Β· 10 quarters on record
This page tracks every 13F SEC filing in which Palogic Value Management, L.P. reported a position in ISHARES TR (CMBS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Palogic Value Management, L.P. underperformed the S&P 500 by β14.3% annually on this CMBS position. Timing score: 75% (6/8 decisions correct). Average cost basis: $45.63. Maximum drawdown during holding period: β2.4%.
β Significantly underperformed the S&P 500 by 14.3% ann.
8 quarters analyzed
π― Smart timing β consistently buying dips and trimming near peaks.
6 of 8 add/trim decisions correct
Best entry: $43.46 (2023 Q4) Β· Worst: $48.21 (2025 Q3)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
8 adds Β· 1 trim. Bought during 1 of 1 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.56% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size